Inestom

Levocarnitine, the active ingredient in Inestom, is a carnitine supplement presented as an oral supplement for oral use. It treats carnitine deficiency and supports energy metabolism in individuals with metabolic disorders.

GNH USA supplies Inestom as a licensed, GDP-compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide.

Inestom provides levocarnitine supplementation for disorders of fatty‑acid metabolism and related energy deficits. - Carnitine deficiency: restores normal carnitine levels and improves fatty‑acid oxidation. - Energy metabolism support: enhances mitochondrial beta‑oxidation to aid patients with low energy states. - Metabolic disorders adjunct: used alongside other therapies to support metabolic function in inherited or acquired conditions.

Adverse reactions may occur with levocarnitine supplementation.

Common Side Effects: - Nausea: mild to moderate stomach upset. - Vomiting: occasional episodes after ingestion. - Abdominal discomfort: cramping or pain. - Diarrhea: loose stools. - Headache: transient mild headache. - Muscle cramps: occasional stiffness.

Serious or Rare Side Effects: - Anaphylaxis: severe allergic reaction requiring immediate medical attention. - Seizures: rare occurrence, especially in predisposed individuals. - Cardiac arrhythmia: irregular heart rhythm. - Severe hypotension: marked drop in blood pressure. - Elevated liver enzymes: indication of hepatic stress. - Rhabdomyolysis: muscle breakdown leading to kidney injury.

Use levocarnitine with appropriate clinical oversight and monitor for specific concerns. - Assess renal function: adjust use in patients with severe renal impairment. - Monitor for hypersensitivity: discontinue if severe allergic reaction occurs. - Use cautiously in epilepsy: may lower seizure threshold. - Avoid in known levocarnitine hypersensitivity: contraindicated. - Pregnancy and lactation: consult a healthcare professional before use. - Store at ambient temperature: keep in original container, protect from moisture and direct sunlight.

Levocarnitine may interact with several medications; awareness of interaction severity guides clinical decisions.

Major Interactions (Avoid): - Valproic acid: can reduce plasma carnitine levels, worsening deficiency. - Cisplatin: concurrent use may increase nephrotoxicity risk. - Warfarin: potential alteration of INR values.

Moderate Interactions (Monitor Closely): - Phenobarbital: may increase levocarnitine metabolism. - Thyroid hormones: may affect carnitine requirements. - Metformin: monitor renal function when combined.